United States · Series B startup

Who invested in SignalPath

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 15 Nov 2026

$18Mraised across 1 round since 2019, from 1 source

Latest round
Series B, $18MOct 2019
Investors
0
See who backed them

The rounds

  1. Oct 2019
    Series B$18M

    No investor was named in the report.

    Reported by FinSMEsSEC filing: $18M sold, first sale Oct 2019

Funding filed with regulators

SignalPath filed 4 raises, $34M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Oct 2019$18M5 investorsequitySEC Form D
  2. Dec 2017$8.0M4 investorsequitySEC Form D
  3. Jan 2017$5.0M4 investorsequitySEC Form D
  4. Jan 2016$3.0M5 investorsequitySEC Form D

Founders and team

From SignalPath's own website and the SEC filings it signed: 7 on the team.

  • Stephen GillettChairman and CEO
  • Myoung ChaChief Product Officer
  • Scott BurkeChief Technology Officer
  • Utpal KoppikarChief Financial Officer
  • Alan CoxExecutive Officeri
  • Bradford HirschExecutive Officer, Directori
  • Ira GrossmanExecutive Officeri

On the board, as filediGabriel GoncalvesRobert HarringtonRobert Sussman

Quick answers about SignalPath

How much has SignalPath raised?

SignalPath has raised $18M across 1 round since 2019.

When did SignalPath last raise?

SignalPath's most recent round was a Series B of $18M in Oct 2019.

What was SignalPath's biggest round?

Its most recent round, $18M in Oct 2019, is also its largest on record.

What stage is SignalPath at?

SignalPath's latest named round is a Series B, in Oct 2019.

Where is SignalPath based?

SignalPath is based in the United States.

Companies like SignalPath

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.